Intelligence

Turkey's pharmaceutical pricing system undergoes a major restructuring with the publication of the New Pricing Communiqué on August 29, 2026, implementing significant changes including increased Euro/TRY conversion rates, incentive mechanisms for first generic market entry, and the introduction of value-based pricing concepts. The new regulations establish detailed provisions for special product categories while leaving certain implementation details to future secondary legislation.

Turkey has become a major destination for medical tourism, but when treatment goes wrong abroad, patients often don't know their legal rights. This guide examines the regulatory framework governing health tourism in Turkey, common causes of medical malpractice in cosmetic and dental procedures, and the practical steps foreign patients can take to pursue compensation claims under Turkish law.

Understanding patient rights in Turkey is essential for anyone receiving medical treatment, whether in public or private facilities. This guide explains the legal protections available to all patients, the core rights guaranteed by Turkish law, and the practical steps you can take when those rights are violated.

Turkey's pharmaceutical regulatory landscape has evolved with new naming guidelines for human medicinal products. The Turkish Medicines and Medical Devices Agency has established comprehensive procedures for assessing product name similarity, incorporating INN root analysis and automated screening systems. These regulations introduce structured evaluation criteria and appeal mechanisms that will reshape how pharmaceutical companies approach product naming in the Turkish market.

Turkey's Pharmaceutical and Medical Devices Agency has published new guidelines establishing comprehensive naming standards for medicinal products, introducing systematic evaluation criteria and procedures for assessing name similarity and acceptability. The guidelines implement a scoring system through TIBAS that compares proposed names against existing databases, while also addressing international nonproprietary name conflicts and promotional language restrictions.

2 Temmuz 2026 tarihli ve 33298 sayılı Resmî Gazete'de yayımlanan Geleneksel Bitkisel Tıbbi Ürünler Ruhsatlandırma Yönetmeliğinde Değişiklik Yapılmasına Dair Yönetmelik (“Değişiklik Yönetmeliği”) ile geleneksel bitkisel tıbbi ürünlerin ruhsatlandırılmasına ilişkin usul ve esaslarda önemli değişiklikler yapılmıştır.